Park MS - Search Results

1

Efficacy of first-line doxorubicin and ifosfamide in myxoid liposarcoma.

Katz D, Boonsirikamchai P, Choi H, Lazar AJ, Wang WL, Xiao L, Park MS, Ravi V, Benjamin RS, Araujo DM. Katz D, et al. Among authors: park ms. Clin Sarcoma Res. 2012 Jan 24;2(1):2. doi: 10.1186/2045-3329-2-2. Clin Sarcoma Res. 2012. PMID: 22587772 Free PMC article.

2

New insights into the hemangiopericytoma/solitary fibrous tumor spectrum of tumors.

Park MS, Araujo DM. Park MS, et al. Curr Opin Oncol. 2009 Jul;21(4):327-31. doi: 10.1097/CCO.0b013e32832c9532. Curr Opin Oncol. 2009. PMID: 19444101 Review.

3

Inhibiting the VEGF-VEGFR pathway in angiosarcoma, epithelioid hemangioendothelioma, and hemangiopericytoma/solitary fibrous tumor.

Park MS, Ravi V, Araujo DM. Park MS, et al. Curr Opin Oncol. 2010 Jul;22(4):351-5. doi: 10.1097/CCO.0b013e32833aaad4. Curr Opin Oncol. 2010. PMID: 20485168 Review.

4

Activity of temozolomide and bevacizumab in the treatment of locally advanced, recurrent, and metastatic hemangiopericytoma and malignant solitary fibrous tumor.

Park MS, Patel SR, Ludwig JA, Trent JC, Conrad CA, Lazar AJ, Wang WL, Boonsirikamchai P, Choi H, Wang X, Benjamin RS, Araujo DM. Park MS, et al. Cancer. 2011 Nov 1;117(21):4939-47. doi: 10.1002/cncr.26098. Epub 2011 Apr 8. Cancer. 2011. PMID: 21480200 Free PMC article.

5

Solitary fibrous tumor: a clinicopathological study of 110 cases and proposed risk assessment model.

Demicco EG, Park MS, Araujo DM, Fox PS, Bassett RL, Pollock RE, Lazar AJ, Wang WL. Demicco EG, et al. Among authors: park ms. Mod Pathol. 2012 Sep;25(9):1298-306. doi: 10.1038/modpathol.2012.83. Epub 2012 May 11. Mod Pathol. 2012. PMID: 22575866 Free article.

6

The role of chemotherapy in advanced solitary fibrous tumors: a retrospective analysis.

Park MS, Ravi V, Conley A, Patel SR, Trent JC, Lev DC, Lazar AJ, Wang WL, Benjamin RS, Araujo DM. Park MS, et al. Clin Sarcoma Res. 2013 May 11;3(1):7. doi: 10.1186/2045-3329-3-7. Clin Sarcoma Res. 2013. PMID: 23663788 Free PMC article.

7

Incidence, demographics, and survival of malignant hemangioendothelioma in the United States.

Paulson KG, Ravi V, Rubin BP, Park M, Loggers ET, Cranmer LD, Wagner MJ. Paulson KG, et al. Cancer Med. 2023 Jul;12(14):15101-15106. doi: 10.1002/cam4.6181. Epub 2023 Jun 1. Cancer Med. 2023. PMID: 37260142 Free PMC article.

8

Incidence and Presenting Characteristics of Angiosarcoma in the US, 2001-2020.

Wagner MJ, Ravi V, Schaub SK, Kim EY, Sharib J, Mogal H, Park M, Tsai M, Duarte-Bateman D, Tufaro A, Loggers ET, Cranmer LD, Chau B, Hassett MJ, Grilley-Olson J, Paulson KG. Wagner MJ, et al. JAMA Netw Open. 2024 Apr 1;7(4):e246235. doi: 10.1001/jamanetworkopen.2024.6235. JAMA Netw Open. 2024. PMID: 38607625 Free PMC article.

9

Cediranib in Combination with Olaparib in Patients without a Germline BRCA1/2 Mutation and with Recurrent Platinum-Resistant Ovarian Cancer: Phase IIb CONCERTO Trial.

Lee JM, Moore RG, Ghamande S, Park MS, Diaz JP, Chapman J, Kendrick J, Slomovitz BM, Tewari KS, Lowe ES, Milenkova T, Kumar S, Dymond M, Brown J, Liu JF. Lee JM, et al. Among authors: park ms. Clin Cancer Res. 2022 Oct 3;28(19):4186-4193. doi: 10.1158/1078-0432.CCR-21-1733. Clin Cancer Res. 2022. PMID: 35917514 Free PMC article.

10

Clinical Characteristics and Treatment Outcomes of Pulmonary Diseases Caused by Coinfections With Multiple Nontuberculous Mycobacterial Species.

Kim S, Woo A, Yong SH, Leem AY, Lee SH, Lee SH, Kim SY, Chung K, Kim EY, Jung JY, Kang YA, Park MS, Kim YS, Park Y. Kim S, et al. Among authors: park ms. J Korean Med Sci. 2024 May 27;39(20):e167. doi: 10.3346/jkms.2024.39.e167. J Korean Med Sci. 2024. PMID: 38804011 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,209 results

Search Page